A Phase 3, Randomized, Partially Double-Blind Trial to Evaluate the Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine in Healthy Toddlers 12 Through 23 Months of Age With 2 Prior Infant Doses of Prevenar 13

A Study of 20vPnC in Healthy Babies Aged 12 to 23 Months Old who Got 2 Doses of Prevenar 13 Before They Were 12 Months Old

Category & Conditions: Vaccine-related Conditions

Medicine: PF-06482077

ClinicalTrials.gov Identifier (NCT): NCT05408429

Protocol ID: B7471027

Print Download

Open Plain Language Summary Result: Click here